Nervonik announced that it closed a $13 million Series A funding round to support its opioid-free peripheral nerve ...

Progress Mushonga, 49, from Southend-on-Sea in Essex, said she had a "real sense of peace" after her successful heart ...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 35th Annual ...

Farrell replaces Tom Frinzi on the heels of a challenging year for the eye implant maker marked by a demand slowdown in China, its largest market.

Medical Device Network investigates the reality of in-space manufacturing, and what challenges will first need to be overcome ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the Fusion Biopsy ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

A pacemaker modified for newborns’ tiny bodies safely and effectively stabilized their heart rhythms for up to two years, ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality.

In recent years, we have seen an increase in the number of deaths caused by cardiac arrest. Worse, most of them were ...